ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 10:57 am Sale |
2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% |
-93,333 (Position Closed) |
Filing |
| 2022-05-02 4:30 pm Purchase |
2022-04-21 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
ADAGE CAPITAL PARTNERS GP L.L.C. | 93,333 8.080% |
93,333 (New Position) |
Filing |
| 2021-02-11 08:25 am Sale |
2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% |
-74,167 (Position Closed) |
Filing |